InvestorsHub Logo
Followers 118
Posts 11972
Boards Moderated 0
Alias Born 12/18/2003

Re: goldenisla post# 11151

Tuesday, 02/21/2017 8:58:29 AM

Tuesday, February 21, 2017 8:58:29 AM

Post# of 232331
Yes, and even without adjusting doses we have VERY good results in 62.5 % patients , in monotherapy !!! , not 36 % in adjunct .

But for patients CCR5 negative with drug resistance it will be
life saving .



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News